Johnson Controls (JCI)
NYSEIndustrialsBuilding Products & EquipmentSnapshot 2026-07-07
$140.62-1.47%
Close 2026-07-07 · 1-day change
Reading JCI? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track JCI free→NYSEIndustrialsBuilding Products & EquipmentSnapshot 2026-07-07
Reading JCI? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track JCI free→A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a durable compounder with a focus on organic sales growth. The current thesis state is intact, as recent financial results are strong and management is on track with key priorities.
The market seems to expect a moderate level of fragility in JCI's execution quality, which is reflected in a stretched valuation compared to peers. There is an expectations gap of 0.18, indicating that some cautious sentiment is priced into the stock.
Fundamentals are likely to continue improving, with management targeting organic sales growth of around 6% and adjusted EPS of approximately $4.85 for fiscal 2026. However, there is a low probability of missing these targets, especially given recent trends in the industry.
The long-term thesis hinges on the performance of sector bellwethers like TT, CARR, and LII. If these companies continue to exceed earnings expectations, it could provide a favorable backdrop for JCI. Conversely, any negative guidance from these peers could pose risks to JCI's momentum.
In summary, JCI's fundamentals appear solid, but the investment thesis is sensitive to broader industry trends. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat and the addition of a new board member may enhance strategic decision-making, both of which support a more favorable outlook for the company. There are no significant threats noted at this time.
as of 2026-07-07
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: This growth rate shows there is ongoing demand. It also means the strategy is working.
Confirms:Organic sales growth reported at ~6% or higher for Q3 2026.
Disproves:Organic sales growth reported below ~6% for Q3 2026.
Why it matters: Hitting this EPS target would confirm strong financial performance and growth momentum.
Confirms:Adjusted EPS reported at ~$1.28 or higher for Q3 2026.
Disproves:Adjusted EPS reported below ~$1.28 for Q3 2026.
Why it matters: Her experience may help with decisions and governance. This could affect long-term growth.
Confirms one read:They shared good plans after her appointment. They made positive decisions.
Confirms the other:There were no clear changes or improvements after her appointment.
Why it matters: The results will show how much debt the company can manage and its financial health.
Confirms one read:The company has tendered at least $90 million of senior notes.
Confirms the other:Less than $90 million of senior notes are tendered.
Why it matters: Changes in backlog growth can indicate future revenue trends and demand strength.
Confirms one read:Backlog growth is at or above 26% compared to last year.
Confirms the other:Backlog growth is below 26% compared to last year.
Why it matters: Increasing the cap shows they manage cash flow well. It also shows financial flexibility.
Confirms:Announcement of the Aggregate Tender Cap raised to $117 million or more.
Disproves:No announcement of an increase in the Aggregate Tender Cap by the June 18 deadline.
Why it matters: This EPS target shows the company's profit goals. Meeting it shows good cost control and growth.
Confirms:Fiscal 2026 adjusted EPS reported at or above $4.85.
Disproves:Fiscal 2026 adjusted EPS was below $4.85.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.